Hints and tips:
Related Special Reports
...Bristol Myers Squibb is working on contingency plans to “protect the continuity of supply” of medicine in preparation for draft US legislation seeking to restrict Chinese pharmaceutical companies over national...
...Bristol Myers Squibb raised $13bn in a large bond deal on Wednesday that will help fund two acquisitions....
...Bristol Myers Squibb launched a potentially jumbo-sized bond deal on Wednesday to help fund two acquisitions....
...Bristol Myers Squibb has agreed to buy neuroscience biotech Karuna Therapeutics for $14bn, gaining access to a promising schizophrenia drug....
...“We have a broader forex impact that we cannot mitigate but others can,” Myers said. The company has also accumulated a significant debt pile as a result of its woes on the continent....
...“We see a number of tranches of potential value, whether that is to us or someone else,” said chief executive Jonathan Myers, adding that while the company had received unsolicited approaches in recent months...
...Bristol Myers Squibb has pushed out by one year its sales target for a new crop of drugs, guiding that the pharmaceutical company’s goal of at least $10bn would now not be achieved until 2026....
...Other earnings: Merck, Caterpillar, Honeywell, Bristol Myers Squibb, Altria, Northrop Grumman, Royal Caribbean Cruises, Southwest Airlines, American Airlines, Harley-Davidson and Hertz are reporting before...
...Still, that has not stopped investors from fretting about pipeline replacement at companies such as Bristol Myers Squibb (BMS), Sanofi and Roche....
...The town of Bodø in Norway will host a ceremony on Saturday to celebrate its tenure as one of the 2024 European Capitals of Culture....
...Pharma: Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie will also report earnings before the market opens....
...Pharmaceutical company Bristol Myers Squibb fell 3.5 per cent after the federal US drug regulator delayed its decision to expand the use of a cancer therapy and as rival Bayer stopped a late-stage study...
...“G minor gives me a yellow, golden colour,” explains Myers, who is known for fusing classical music with other genres — and is a former winner of UK reality TV show Britain’s Got Talent....
...Caforio said he would continue as executive chair for a transitional period, the length of which would be decided by the board....
...Caforio said he would continue as executive chair of BMS for a transitional period, the length of which would be decided by the BMS board....
...Oxford-based Exscientia is working with Sanofi and Bristol Myers Squibb, among others, and Insitro has a deal with Bristol Myers, while Owkin is also collaborating with Sanofi....
...“Bottom line is that it is always better as a nation to have your own oil,” said Amy Myers Jaffe, a professor at NYU....
...A modest little painting, wrapped in brown paper. One for the skip, thinks Nicola (Dorothea Myer-Bennett), until they notice the signature. Is that A Hiller? Or A Hitler?...
...Earnings are also expected from Merck, Caterpillar, Honeywell, Bristol Myers Squibb, Altria, Northrop Grumman, Royal Caribbean Cruises, Southwest Airlines, American Airlines, Harley-Davidson and Hertz before...
...The impact could be significant for companies such as Bristol Myers Squibb. Its blood thinner Eliquis is expected to account for more than a quarter of sales in 2026, according to Visible Alpha....
...“I’m an advocate for the shelf charter,” said Brian Brooks, a partner of DC law firm O’Melveny & Myers and a former acting comptroller of the currency....
...With Laura Myers, an LCP partner, he is co-author of the report: “Magnetic Pensions: A New Blueprint for the DC Pensions Landscape”, available at lcp.com...
...“This is a problem because it is really hard once you have got someone set up with a scheme to then increase charges,” said Emma Douglas, head of workplace pension savings with Aviva....
...A price to forward earnings multiple of over 50 values the stock more like a tech company than a pharma group. Bristol Myers Squibb trades on just seven times earnings while Pfizer is on 20 times....
...a powerful boost to revenues....
International Edition